A second-site mutation that restores replication of a Tat- defective human immunodeficiency virus

Journal of Virology

Volumn 73, Issue 4, 1999, Pages 2781-2789

  Verhoef, Koen ^a   Berkhout, Ben ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; MUTANT PROTEIN; TYROSINE;

AMINO ACID SUBSTITUTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; EXON; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN STRUCTURE; SITE DIRECTED MUTAGENESIS; VIRUS GENE; VIRUS GENOME; VIRUS MUTATION; VIRUS REPLICATION;

EID: 0032976394     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.4.2781-2789.1999     Document Type: Article

References (47)

1. Amendt, B. A., Z. Si, and C. M. Stolzfus. 1995. Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors. Mol. Cell. Biol. 15:4606-4615.
2. Back, N. K. T., M. Nijhuis, W. Keulen, C. A. B. Boucher, B. B. Oude Essink, A. B. P. van Kuilenburg, A. H. Van Gennip, and B. Berkhout. 1996. Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme. EMBO J. 15:4040-4049.
3. Bayer, P., M. Kraft, A. Ejchart, M. Westendorp, R. Frank, and P. Rosch. 1995. Structural studies of HIV-1 Tat protein. J. Mol. Biol. 247:529-535.
4. Berkhout, B., and A. T. Das. Functional analysis of RNA signals in the HIV-1 genome by forced evolution. In J. Barciszewski and B. F. C. Clark (ed.), RNA biochemistry and biotechnology, in press. Kluwer Academic Publishers, Dordrecht, The Netherlands.
5. Berkhout, B., A. Gatignol, J. Silver, and K. T. Jeang. 1990. Efficient transactivation by the HIV-2 Tat protein requires a duplicated TAR RNA structure. Nucleic Acids Res. 18:1839-1846.
6. Berkhout, B., and B. Klaver. 1993. In vivo selection of randomly mutated retroviral genomes. Nucleic Acids Res. 21:5020-5024.
7. Berkhout, B., B. Klaver, and A. T. Das. 1997. Forced evolution of a regulatory RNA helix in the HIV-1 genome. Nucleic Acids Res. 25:940-947.
8. Berkhout, B., R. H. Silverman, and K. T. Jeang. 1989. Tat trans-activates the human immunodeficiency virus through a nascent RNA target. Cell 59:273-282.
9. Braddock, M., A. M. Thorburn, A. Chambers, G. D. Elliot, G. J. Anderson, A. J. Kingsman, and S. M. Kingsman. 1990. A nuclear translational block imposed by the HIV-1 U3 region is relieved by the Tat-TAR interaction. Cell 62:1123-1133.
10. Chun, R. F., O. J. Semmes, C. Neuveut, and K.-T. Jeang. 1998. Modulation of Sp1 phosphorylation by human immunodeficiency virus type 1 Tat. J. Virol. 72:2615-2629.
11. 3Lys. J. Virol. 69:3090-3097.
12. Das, A. T., B. Klaver, B. I. F. Klasens, J. L. B. van Wamel, and B. Berkhout. 1997. A conserved hairpin motif in the R-U5 region of the human immunodeficiency virus type 1 RNA genome is essential for replication. J. Virol. 71:2346-2356.
13. Das, A. T., A, P. van Dam, B. Klaver, and B. Berkhout. 1998. Improved envelope function selected by long-term cultivation of a translation-impaired HIV-1 mutant. Virology 244:552-562.
14. Dingwall, C., I. Ernberg, M. J. Gait, S. M. Green, S. Heaphy, J. Karn, A. D. Lowe, M. Singh, M. A. Skinner, and R. Valerio. 1989. Human immunodeficiency virus 1 tat protein binds trans-activating-responsive region (TAR) RNA in vitro. Proc. Natl. Acad. Sci. USA 86:6925-6929.
15. Freund, J., L. Vertesy, K. P. Koller, V. Wolber, D. Heintz, and H. R. Kalbitzer. 1995. Complete 1H nuclear magnetic resonance assignments and structural characterization of a fusion protein of the alpha-amylase inhibitor tendamistat with the activation domain of the human immunodeficiency virus type 1 Tat protein. J. Mol. Biol. 250:672-688.
16. Garcia-Martinez, L. F., G. Mavankal, J. M. Neveu, W. S. Lane, D. Ivanov, and R. B. Gaynor. 1997. Purification of a Tat-associated kinase reveals a TFIIH complex that modulates HIV-1 transcription. EMBO J. 16:2836-2850.
17. Harrich, D., C. Ulich, L. F. Garcia-Martinez, and R. B. Gaynor. 1997. Tat is required for efficient HIV-1 reverse transcription. EMBO J. 16:1224-1235.
18. Hauber, J., M. Malim, and B. Cullen. 1989. Mutational analysis of the conserved basic domain of human immunodeficiency virus Tat protein. J. Virol. 63:1181-1187.
19. Huang, L. M., A. Joshi, K. Willey, J. Orenstein, and K. T. Jeang. 1994. Human immunodeficiency viruses regulated by alternative trans-activators: genetic evidence for a novel non-transcriptional function of Tat in virion infectivity. EMBO J. 13:2886-2896.
20. Jeang, K.-T. 1998. Tat, Tat-associated kinase, and transcription. J. Biomed. Sci. 5:24-27.
21. Jeang, K. T., R. Chun, N. H. Lin, A. Gatignol, C. G. Glabe, and H. Fan. 1993. In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor. J. Virol. 67:6224-6233.
22. Klaver, B., and B. Berkhout. 1994. Evolution of a disrupted TAR RNA hairpin structure in the HIV-1 virus. EMBO J. 13:2650-2659.
23. Kuppuswamy, M., T. Subramanian, A. Srinivasan, and G. Chinnadurai. 1989. Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis. Nucleic Acids Res. 17:3551-3561.
24. Mancebo, H. S. Y., G. Lee, J. Flygare, J. Tomassini, P. Luu, Y. Zhu, J. Peng, C. Blau, D. Hazuda, D. Price, and O. Flores. 1997. P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev. 11:2633-2644.
25. Martinez, M. A., J. P. Vartanian, and S. Wain-Hobson. 1994. Hypermutagenesis of RNA using human immunodeficiency virus type 1 reverse transcriptase and biased dNTP concentrations. Proc. Natl. Acad. Sci. USA 91:11787-11791.
26. Mikaelian, I., and A. Sergeant. 1992 A general and fast method to generate multiple site-directed mutations. Nucleic Acids Res. 20:376.
27. Mujeeb, A., K. Bishop, B. M. Peterlin, C. Turck, T. G. Parslow, and T. L. James. 1994. NMR structure of a biologically active peptide containing the RNA-binding domain of human immunodeficiency virus type 1 Tat. Proc. Natl. Acad. Sci. USA 91:8248-8252.
28. Myers, G., S. Wain-Hobson, L. E. Henderson, B. Korber, K. T. Jeang, and G. N. Pavlakis. 1994. Human retroviruses and AIDS 1994. A compilation and analysis of nucleic acid and amino acid sequences. Theoretical biology and biophysics. Los Alamos National Laboratory, Los Alamos, N.M.
29. Neuveut, C., and K.-T. Jeang. 1996. Recombinant human immunodeficiency virus type 1 genomes with Tat unconstrained by overlapping reading frames reveal residues in Tat important for replication in tissue culture. J. Virol. 70:5572-5581.
30. Olsthoorn, R. C. L., N. Licis, and J. van Duin. 1994. Leeway and constraints in the forced evolution of a regulatory RNA helix. EMBO J. 13:2660-2668.
31. Olsthoorn, R. C. L., and J. van Duin. 1996. Evolutionary reconstruction of a hairpin deleted from the genome of an RNA virus. Proc. Natl. Acad. Sci. USA 93:12256-12261.
32. Rabson, A. B., and B. J. Graves. 1997. Synthesis and processing of viral RNA, p. 205-262. In J. M. Coffin, S. H. Hughes, and H. E. Varmus (ed.), Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor. N.Y.
33. Seed, B., and J. Y. Sheen. 1988. A simple phase-extraction assay for chloramphenicol acyltransferase activity. Gene 67:271-277.
34. Seigel, L. J., L. Ratner, S. F. Josephs, D. Derse, M. B. Feinberg, G. R. Reyes, S. J. O'Brien, and F. Wong-Staal. 1986. Trans-activation induced by human T-lymphotrophic virus type III (HTLV-III) maps to a viral sequence encoding 58 amino acids and lacks tissue specificity. Virology 148:226-231.
35. SenGupta, D. N., B. Berkhout, A. Gatignol, A. M. Zhou, and R. H. Silverman. 1990. Direct evidence for translational regulation by leader RNA and Tat protein of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 87:7492-7496.
36. Siderovski, D. P., T. Matsuyama, E. Frigerio, S. Chui, X. Min, H. Erfle, M. Sumner Smith, R. W. Barnett, and T. W. Mak. 1992. Random mutagenesis of the human immunodeficiency virus type-1 trans-activator of transcription (HIV-1 Tat). Nucleic Acids Res. 20:5311-5320.
37. Silverman, R. H., and D. N. SenGupta. 1990. Translational regulation by HIV leader RNA, TAT, and interferon-inducible enzymes. J. Exp. Pathol. 5:69-77.
38. Taddeo, B., F. Carlini, P. Verani, and A. Engelman. 1996. Reversion of a human immunodeficiency virus type 1 integrase mutant at a second site restores enzyme function and virus infectivity. J. Virol. 70:8277-8284.
39. Tan, R., A. Brodsky, J. R. Williamson, and A. D. Frankel. 1997. RNA recognition by HIV-1 Tat and Rev. Semin. Virol. 8:186-193.
40. Verhoef, K., M. Bauer, A. Meyerhaus, and B. Berkhout. 1998. On the role of the second coding exon of the HIV-1 Tat protein in virus replication and MHC class 1 downregulation. AIDS Res. Hum. Retroviruses 14: 1553-1559.
41. Verhoef, K., A. Klein, and B. Berkhout. 1996. Paracrine activation of the HlV-1 LTR promoter by the viral Tat protein is mechanistically similar to trans-activation within a cell. Virology 225:316-327.
42. Verhoef, K., M. Koper, and B. Berkhout. 1997. Determination of the minimal amount of Tat activity required for human immunodeficiency virus type 1 replication. Virology 237:228-236.
43. 41a. Verhoef, K., R. W. Sanders, V. Fontaine, S. Kitajima, and B. Berkhout. 1999. Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-κB enhancer element into a GABP binding site. J. Virol. 73:1331-1340.
44. Wei, P., M. E. Garber, S.-M. Fang, W. H. Fisher, and K. A. Jones. 1998. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92:451-462.
45. Willey, R. L., E. K. Ross, A. J. Buckler-White, T. S. Theodore, and M. A. Martin. 1989. Functional interaction of constant and variable domains of human immunodeficiency virus type gp120. J. Virol. 63:3595-3600.
46. Xiao, H., C. Neuveut, M. Benkirane, and K.-T. Jeang. 1998. Interaction of the second coding exon of Tat with human EF-1 delta delineates a mechanism for HIV-1-mediated shut-off of host mRNA translation. Biochem. Biophys. Res. Commun. 17:384-389.
47. Yang, X., M. O. Gold, D. N. Tang, D. E. Lewis, E. Aguilar-Cordova, A P. Rice, and C. H. Herrmann. 1997. TAK, an HIV Tat-associated kinase, is a member of the cyclin-dependent family of protein kinases and is induced by activation of peripheral blood lymphocytes and differentiation of promonocytic cell lines. Proc. Natl. Acad. Sci. USA 94:12331-12336.